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sus disease activity indexAbstract Background: Systemic lupus erythematosus (SLE) is associated with high cardiovascular
morbidity and mortality. It is frequently underestimated by routine imaging techniques. Aim of the
work was to determine if new echocardiographic imaging modalities like tissue Doppler, can detect
abnormalities in left ventricular function in asymptomatic SLE patients.
Patients and methods: Fifty SLE patients were attending the rheumatology department of the
Kasr El Aini hospital. All patients were subjected to cardiac, musculoskeletal examination, routine
laboratory investigations. Twenty healthy age matched subjects were taken as controls. Ultrasound
examination by two dimensional echocardiography and color tissue Doppler were performed on the
patients and control to obtain the cardiac chamber diameters, systolic and diastolic myocardial
velocities.
218 N.T. Allam et al.Results: SLE patients have an increased prevalence of subclinical LV dysfunction. SLE patients
with positive tissue Doppler ﬁndings were of old age, had long disease duration, high disease activ-
ity and nephritis.
Conclusion: Tissue Doppler velocities have been shown to be a sensitive tool in detecting early
myocardial dysfunction before the occurrence of reduced left ventricular ejection fraction (LVEF).
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis.Open access under CC BY-NC-ND license.1. Introduction
Systemic lupus erythematosus (SLE) is a multi organ auto-
immune disease associated with high cardiovascular morbid-
ity and mortality that primarily affects young women [1].
Patients with SLE have increased prevalence of subclinical
left ventricular dysfunction which may be a prognostic indi-
cator of cardiac mortality and morbidity. The mechanisms
by which SLE might directly induce changes in the left ven-
tricular structure are many fold and include underlying
inﬂammatory processes leading to subclinical vasculitis,
myocarditis or vascular stiffening and pre clinical coronary
artery disease [2].
In this regard the standard method for evaluating cardiac
function used in clinical practice often lacks sensitivity to detect
myocardial abnormalities in SLE [3].
Tissue Doppler imaging is a non invasive technique
widely used to detect subtle, asymptomatic myocardial func-
tion abnormalities. It is useful as it can identify early left
ventricular dysfunction and allow reliable screening for sub-
clinical cardiac involvement in patients with increased risk of
cardiovascular disease [4]. Tissue Doppler measures regional
systolic and diastolic myocardial velocities and has been
used for quantitative analysis of global and regional myocar-
dial function [5]. Myocardial velocity indicates the rate at
which particular point that the myocardium moves toward
or away from the transducer. In apical views the base of
the heart moves toward the apex in systole and represents
positive polarity and moves away from the apex to yield
the early diastolic (e0) and late negative (a0) diastolic waves
[4]. Myocardial performance index (MPI) is a simple, nonin-
vasive and an easy method to estimate global left ventricular
systolic and diastolic functions. MPI is the sum of isovolu-
metric contraction time and isovolumetric relaxation time di-
vided by the ejection time [6].
We aimed in this work to determine if the new echocar-
diographic imaging modalities like tissue Doppler, can detect
abnormalities in left ventricular function in asymptomatic
SLE patients.2. Patients and methods
Fifty patients with SLE and 20 age and sex matched healthy
controls were enrolled into the study. All patients were re-
cruited from the outpatient and inpatient sections of the
rheumatology and rehabilitation department, faculty of med-
icine, Cairo university hospitals. They were diagnosed as
SLE based on the revised criteria deﬁned by the American
college of Rheumatology [7].2.1. Exclusion criteria
SLE patients with typical symptoms or signs of heart failure,
signiﬁcant valvular heart disease, history or symptoms of cor-
onary heart disease.
All patients were subjected to full history taking, general,
cardiac and musculoskeletal examination, body mass in-
dex(wt/ht2), routine laboratory investigations (complete blood
count, liver and kidney function, lipid proﬁle, and erythrocyte
sedimentation rate), chest X-ray. Disease activity assessment
by SLE disease activity index (SLEDAI) [8]. Data regarding
the presence of hypertension, diabetes mellitus, and hyperlip-
idaemia were collected and recorded from patients and con-
trols to assess the cardiovascular risk factors. None of our
patients or controls was a smoker.
According to SLEDAI score we classiﬁed our patients into
two groups: [8]; 30 Patients with SLEDAI > 10 denoting ac-
tive disease and 20 patients with SLEDAI < 10 denoting inac-
tive disease.
Cardiac function was assessed in all patients and controls
by:
(1) The conventional two dimensional (2D) transthoracic
echocardiography by which the left atrial, the left ven-
tricular (LV) dimensions and septal wall thickness were
measured according to the published recommendations
of the American society of Echocardiography [9].
End-diastolic and end-systolic LV volumes and ejections
fraction were measured using apical 4-chamber and
2-chamber views.
(2) Tissue Doppler: pulsed-wave tissue Doppler imaging
was performed, the sample volume was placed on the
lateral and septal mitral annulus in the apical 4-chamber
view to measure the following parameters; peak systolic
myocardial velocity(s), peak early (e), and late (a) myo-
cardial diastolic velocities, isovolumetric contraction
time (ICT) (which represents the distance between the
end of diastolic velocity and the beginning of systolic
velocity), isovolumetric relaxation time (IRT) (which
represents the distance of the end of systolic velocity
and the onset of diastolic velocity), ejection time (ET)
(which is the duration of systolic velocity proﬁl), myo-
cardial performance index (MPI) (the sum of ICT and
IRT divided by ET). The mean normal value of MPI
is 0.39 ± 0.05 for the LV. in adults, values of the LV
index <0.4 is considered normal .Higher index values
>0.4 were considered as an index for cardiac dysfunc-
tion [6]. MPI by tissue Doppler has the advantage of
assessing both regional and global myocardial perfor-
mance. [9,10]
Table 1 The clinical characteristics of SLE patients (n= 50).
Clinical manifestations No. of cases %
Constitutional manifestation
Fever 44 88
Weight loss 16 32
Lymphadenopathy 7 14
Mucutaneous manifestations
Oral ulcers 32 64
Malar rash 44 88
Discoid rash 8 16
Photosensitivity 29 58
Alopecia 8 16
Musculoskeletal manifestation
Arthralgia 32 64
Arthritis 13 26
Myalgia 26 52
Myositis 2 4
Vascular manifestations
Raynaud’s phenomenon 8 16
Cutaneous vasculitis 2 4
DVT 2 4
Neurological manifestations
Headache 3 6
Seizures 1 2
Psychosis 3 6
Pulmonary manifestations
Pleurisy 22 44
Dry cough 7 14
Pleural eﬀusion 3 6
Hypertension 25 50
Diabetes 6 12
Dyslipidemia 23 46
DVT, deep venous thrombosis.
Table 2 Laboratory and immunological characteristics of
SLE patients (n= 50).
Laboratory data Range Mean ± SD
Hb (gm/dl) 6.2–14 10.44 ± 1.74
WBC (cell/mm3) 2.3–15.5 7.11 ± 5.15
Platelets (platelet/mm3) 17–788 272.96 ± 116.4
ESR (mm/hr)(1st hr) 20–150 69.42 ± 36.84
AST (U/L) 10–40 19 ± 8.19
ALT (U/L) 7 – 40 18.4 ± 3.29,
Albumin (g/dl) 2.2–4.8 3.29 ± 0.57
Creatinine (mg/dl) 0.3–3 0.78 ± 0.47
24-h urinary protein (gm/24hr) 0.01–3 1.14 ± 1.16
TG (mg/dl) 63–424 167.91 ± 86.43
Cholesterol (mg/dl) 137–431 220 ± 63.16
Positive ANA (n, %) 50 100
Positive DNA (n, %) 35 70
Positive ACL (n, %) 14 28
Consumed C3 andC4 (n, %) 29 28
Hb, hemoglobin; WBCs, white blood cells; ESR, erythrocyte sedi-
mentation rate; AST, aspartate transaminase; ALT, alanine trans-
aminase; TG, triglyceride; ANA, antinuclear antibodies; ACL,
anticardiolipin; C3, C4, complement 3 and 4.
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all participants provided informed consent.
Data were coded and entered using the statistical package
SPSS version 15. Data were summarized using descriptive sta-
tistics: mean, standard deviation, minimal and maximum val-
ues for quantitative variables and number and percentage for
qualitative values. Statistical differences between groups were
tested using the Chi Square test for qualitative variables, inde-
pendent sample t test for quantitative normally distributed
variables while the Nonparametric Mann Whitney test was
used for quantitative variables which are not normally distrib-
uted. Correlations were done to test for linear relations be-
tween variables. P-values less than or equal to 0.05 were
considered statistically signiﬁcant. To measure the association
between the possible cardiac risk factors and myocardial dys-
function we used the OR. The 95% conﬁdence interval (CI)
is used to estimate the precision of the OR.
3. Results
This case control study compromised two groups; The 1st
group included 50 female SLE patients. Their ages ranged from
18 to 50 years with a mean of 26.82 ± 6.96 years, their body
mass index (BMI) ranged from 20 to 39 kg/m2 with a mean
of 26.86 ± 5.03 and their age of disease onset ranged from 17
to 40 years with a mean of 22.18 ± 6.29 and the duration of
disease ranged from 1 to 15 years with a mean of 9.2 ± 4.91.
The 2nd group included 20 age and sex matched healthy volun-
teers that served as the control. Their ages ranged from 17 to 52
with a mean of 27.5 ± 8.57, BMI ranged from 26 to 39 kg/m2
with a mean of 27.4 ± 5.034.
By comparing between SLE patients and control, we found
no statistically signiﬁcant difference between both groups
regarding their age, BMI, diastolic BP (P= 0.568, 0.548,
0.120 respectively) however systolic BP was signiﬁcantly higher
in SLE patients compared to the control (p= 0.001).
The clinical and laboratory characteristics of SLE patients
are shown in Tables 1 and 2.
All our patients (100%) were on corticosteroids with a mean
dose of 20 ± 9.34 mg/day and ranging between 5 and 40 mg.,
23 (46%) patients were on a combination therapy of steroid,
hydroxychloroquine and azathioprine, 16 (32%) patients were
on steroid, hydroquine and cyclophosphamide, 11 (22%) pa-
tients were on steroid and hydroquine only, 25 (50%) of our pa-
tients were on antihypertensives, 6 (12%)of our patients were
receiving anti diabetic treatment and 15 (30%) of them were
on lipid lowering treatment.
3.1. Echocardiographic ﬁndings in SLE patients
3.1.1. 2D echocardiography in SLE patients
Left Atrial dimension (LA) ranged from 2 to 4.7 cm with a
mean of 3.23 ± 0.56, left ventricular end diastolic dimensions
(LVED) ranged from 3.7 to 5.8 cm with a mean of
4.69 ± 0.56, left ventricular end systolic dimensions (LVES)
ranged from 2. to 3.6 cm with a mean of 2.84 ± 0.42, septal
wall thickness (SWT) ranged from 0.8 to 2 cm with a mean
of 1.2 ± 0.29, posterior wall thickness (PWT) ranged from
0.9 to 1.9 cm with a mean of 1.45 ± 0.28, fraction shortening
(FS) ranged from 29% to 50% with a mean of 39.4%±
6.04%, ejection fraction(EF) ranged from 60% to 80% witha mean of 70%± 7.70%, peak early diastolic velocity of mi-
tral inﬂow(PW-E) ranged from 0.39 to 1 m/s with a mean of
220 N.T. Allam et al.0.7 ± 0.15, peak late diastolic velocity of mitral inﬂow (PW-A)
ranged from 0.4 to 1.35 m/s with a mean of 0.61 ± 0.17, and
the ratio between E/A ranged from 0.72 to 1.59 m/s with a
mean of 1.16 ± 0.28.
3.2. Tissue Doppler ﬁndings in SLE patients
TissueDoppler imaging ﬁndings at septum (TDI at septum): peak
systolic myocardial velocity (S wave) ranged from 0.05 to
0.27 cm/s with a mean of 0.1 ± 0.04, peak early diastolic myo-
cardial velocity (E wave) ranged from 0.05 to 0.27 cm/s with a
mean of 0.12 ± 0.04, peak late diastolic myocardial velocity
(A wave)ranged from 0.06 to 0.13 cm/s with mean of
0.1 ± 0.04, isovolumetric contraction time (ICT) ranged from
26 to 89 ms with a mean of 56.09 ± 16.62, isovolumetric relax-
ation time (IRT) from 28 to 96 mswith amean of 66.22 ± 16.91
and themyocardial performance index ranged (MPI)from 0.2 to
o.74 with a mean of 0.49 ± 0.11.
Tissue Doppler imaging ﬁndings at lateral mitral annulus
(TDI at mitral): peak systolic myocardial velocity ranged from
0.04 to 0.14 cm/s with a mean of 0.1 ± 0.01, peak early dia-
stolic myocardial velocity ranged from 0.03 to 0.2 cm/s with
a mean of 0.13 ± 0.01, peak late diastolic myocardial velocity
ranged 0.01–0.16 cm/s with a mean of 0.12 ± 0.04, isovolu-
metric contraction time ranged from 37 to 100 m/s with a
mean of 56.9 ± 16.62, isovolumetric relaxation time ranged
from 37 to 107 m/s with a mean of 67.94 ± 18.13, and the
myocardial performance index ranged from 0.27 to 0.98 with
a mean of 0.53 ± 0.17.
Although, all the parameters of 2D echocardiography were
within normal ranges in SLE and controls, the LA dimension
was signiﬁcantly larger in SLE patients than in controls
(p= 0.001). Also SWT was signiﬁcantly higher in SLE pa-
tients compared to controls (p= 0.02). Other parameters such
as LVESD, LVEDD, PWT, EF, FS, PW-E, PW-A, and E/A
showed no statistically signiﬁcant difference between SLE pa-
tients and controls. (Table 3)Table 3 Comparison between SLE patients and controls
regarding 2D echocardiography parameters.
SLE Control p-value Signiﬁcance
LA (cm) 3.23 ± 0.56 2.58 ± 0.35 0.001* S
LVESD (cm) 2.84 ± 0.42 2.79 ± 0.25 0.536 NS
LVEDD (cm) 4.69 ± 0.56 4.65 ± 0.61 0.788 NS
SWT (cm) 1.2 ± 0.29 0.9 ± 0.29 0.020* S
PWT (cm) 1.45 ± 0.28 1.43 ± 0.15 0.548 NS
EF% 70 ± 7.7 71.7 ± 3.31 0.084 NS
FS% 39.4 ± 6.04 39.85 ± 4.53 0.618 NS
PW-E (m/s) 0.7 ± 0.15 0.69 ± 0.15 0.662 NS
PW-A (m/s) 0.61 ± 0.17 0.61 ± 0.14 0.983 NS
E/A ratio 1.16 ± 0.28 1.27 ± 0.78 0.896 NS
LA, left Atrial diameter; LVESD, left ventricular end systolic
dimension; LVEDD, left ventricular end diastolic dimension; SWT,
septal wall thickness; PWT, posterior wall thickness; PW-A, peak
velocity of late diastolic mitral inﬂow; PW-E, peak velocity of early
mitral inﬂow; EF, ejection fraction; FS, fractional shortening; E/A:
the ratio between peak early (e), and late (a) myocardial diastolic
velocities.
S: signiﬁcant, NS: not signiﬁcant.There are statistically signiﬁcant lower values of peak sys-
tolic myocardial velocity at the septum and lateral mitral
annulus (P= 0.004 at both sites), peak early diastolic myocar-
dial velocity at the septum and lateral mitral annulus
(p= 0.018, 0.001 respectively) and peak late diastolic myocar-
dial velocity at the septum and lateral mitral annulus
(p= 0.004, 0.018 respectively) in SLE patients compared to
the controls, while, there is no signiﬁcant difference in isovol-
umetric contraction time at the septum and lateral mitral
annulus between both groups (p= 0.084 at both sites). The
isovolumetric relaxation time at the septum and lateral mitral
annulus is signiﬁcantly prolonged in SLE patients compared to
the control (p= 0.001, 0.002 respectively), also the myocardial
performance index at lateral mitral annulus and septum
showed signiﬁcantly higher values in SLE patients compared
to the control (p= 0.001 at both sites). (Table 4)
Regarding the classiﬁcation of the patient groups according
to their SLEDAI scores, we found a statistically signiﬁcant prev-
alence of hypertension among SLEpatients with SLEDAI > 10
compared to those with SLEDAI < 10 (p= 0.004), while, no
statistically signiﬁcant difference was found between both
groups regarding age, BMI, age of disease onset, disease dura-
tion, hyperlipidemia and diabetes (p= 0.242,0.312,0.341,0.22,
0.064,0.722 respectively).
On comparing patients with SLEDAI > 10 against those
with SLEDAI < 10 regarding tissue Doppler parameters (as
in Table 5) we found; statistically signiﬁcant lower values of
peak systolic myocardial velocity at the septum (p= 0.019)
and lateral mitral annulus (p= 0.013), peak early diastolic
myocardial velocity at the septum (p= 0.013) and lateral mi-
tral annulus(p= 0.001), peak late diastolic myocardial veloc-
ity at the septum(p= 0.013) and lateral mitral annulus (p=
0.002) in patients with SLEDAI > 10 compared to those with
SLEDAI < 10.
While, Isovolumetric relaxation time (IRT) at the septum
(p= 0.001) and lateral mitral annulus (p= 0.003) was found
to be prolonged in patients with SLEDAI> 10 compared to
the other group. While isovolumetric contraction time (ICT) at
the septum (p= 0.235) and lateral mitral annulus (p= 0.125)
did not show signiﬁcant difference between both groups.
Myocardial performance index (MPI) at the septum
(p= 0.001) and lateral mitral annulus (0.002) showed higher
values in patients with SLEDAI > 10 compared to the other
group.
Fourteen (28%) out of the 50 SLE patients were ACL po-
sitive, ten out of them had high MPI (>0.4).A statistically sig-
niﬁcant difference was found in the MPI value between the
group of SLE patients with positive ACL antibodies and those
with negative ACL (p= 0.01)3.3. Cardiac risk factors
The normal values for tissue Doppler parameters were not
properly deﬁned except for MPI. Upon correlation between
tissue Doppler ﬁndings (represented by the MPI) and some
clinical, laboratory ﬁndings we found; signiﬁcant positive cor-
relation between the MPI at the lateral annulus and the septum
and each of the following; age of the patients (p= 0.001 at
both sites), disease duration (p= 0.01, 0.001 respectively),
24 h urinary protein level (p= 0.002, 0.001 respectively) and
SLEDAI (p= 0.002, 0.019 respectively)
Table 5 Comparison between patients with SLEDAI > 10 and those with SLEDAI < 10 regarding tissue Doppler parameters.
SLEDAI > 10 SLEDAI < 10 p-value Signiﬁcant
TDI of septum
S wave (cm/s) 0.09 ± 0.22 0.11 ± 0.04 0.019* S
E wave (cm/s) 0.11 ± 0.03 0.14 ± 0.047 0.013* S
A wave (cm/s) 0.1 ± 0.04 0.11 ± 0.02 0.013* S
IRT (ms) 73.8 ± 12.5 54.8 ± 16.4 0.001* S
ICT (ms) 64.3 ± 14.6 58.7 ± 12.65 0.235 NS
MPI (ratio) 0.54 ± 0.09 0.418 ± 0.101 0.001* S
TDI of lateral mitral annulus
S wave (cm/s) 0.1 ± 0.02 0.15 ± 0.09 0.013* S
E wave (cm/s) 0.11 ± 0.04 0.16 ± 0.03 0.001* S
A wave (cm/s) 0.09 ± 0.057 0.11 ± 0.037 0.002* S
IRT (ms) 74 ± 17.86 58.84 ± 14.65 0.003* S
ICT (ms) 67.03 ± 18.3 59.65 ± 12.7 0.125 NS
MPI (ratio) 0.58 ± 0.17 0.43 ± 0.15 0.002* S
TDI, tissue Doppler imaging; S, peak systolic myocardial velocity; E, peak early myocardial diastolic velocity; A, peak late myocardial diastolic
velocity; ICT, isovolumetric contraction time; IRT, isovolumetric relaxation time; MPI, myocardial performance index; TDI, tissue Doppler; S:
signiﬁcant (p< 0.05), NS: non signiﬁcant.
Table 4 Comparison between SLE patients and controls regarding tissue Doppler parameters.
SLE Control p-value Signiﬁcance
TDI at septum
S wave (cm/s) 0.10 ± 0.04 0.12 ± 0.03 0.004* S
E wave (cm/s) 0.12 ± 0.04 0.15 ± 0.04 0.018* S
A wave (cm/s) 0.10 ± 0.04 0.12 ± 0.03 0.004* S
ICT (ms) 56.9 ± 16.62 56.8 ± 12.92 0.084 NS
IRT (ms) 66.22 ± 16.91 52.60 ± 11.65 0.001* S
MPI (ratio) 0.49 ± 0.11 0.34 ± 0.04 0.001* S
TDI at lateral mitral annulus
S wave (cm/s) 0.10 ± 0.01 0.12 ± 0.03 0.004* S
E wave (cm/s) 0.13 ± 0.01 0.15 ± 0.03 0.001* S
A wave (cm/s) 0.12 ± 0.04 0.15 ± 0.04 0.018* S
ICT (ms) 56.09 ± 16.62 56.8 ± 12.92 0.084 NS
IRT (ms) 67.94 ± 18.13 51.95 ± 18.86 0.002* S
MPI (ratio) 0.53 ± 0.17 0.37 ± 0.04 0.001* S
S, peak systolic myocardial velocity; E, peak early diastolic myocardial velocity; A, peak late diastolic myocardial velocity; ICT, isovolumetric
contraction time; IRT, isovolumetric relaxation time; MPI, myocardial performance index; TDI, tissue Doppler; S, signiﬁcant; NS, not
signiﬁcant; S*:highly signiﬁcant.
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cardiac risk factors; Dyslipidemia OR= 0.29 (95% CI: 0.08–
1.04), diabetes OR= 0.87 (95% CI: 0.14–5.3), hypertension
OR= 0.23 (95% CI: 0.06–0.8), anemia OR= 0.8 (95% CI:
0.23–2.7), and the presence of ACL OR= 0.63 (95% CI:
0.16–2.3).4. Discussion
Cardiac involvement in SLE is prevalent in more than 50% of
cases and includes myocarditis, pericarditis, valvular heart dis-
ease, coronary arterial disease and conduction abnormalities
[11,12]. Because the symptoms of myocardial involvement
are usually clinically silent compared with other cardiac
involvement, its prevalence in 7–10% might have been under-
estimated [3].Also autopsy and cardiac magnetic resonanceimaging showed a higher prevalence of myocarditis up to
40–70%[13].
Standard methods for evaluating cardiac function used in
clinical practice often lack the sensitivity to detect myocardial
abnormalities in SLE [14]. Tissue Doppler echocardiography is
a sensitive echocardiographic technique for the quantitative
assessment of subclinical myocardial dysfunction [15,16].
We conducted this study to evaluate the myocardial func-
tion in SLE by using a relatively new imaging modality (tissue
Doppler) and correlate tissue Doppler ﬁndings with various
clinical, laboratory and disease activity parameters in Egyptian
SLE patients.
Our results showed that all 2D echocardiography parameters
were within the normal range in SLE patients, however we re-
ported statistically signiﬁcant larger LA dimension in SLE pa-
tients compared to controls (3.23 ± 0.56 vs. 2.58 ± 0.35,
p= 0.001). Similar ﬁndings were reported in the following
222 N.T. Allam et al.studies: [17] (3.62 ± 0.67 vs. 3.28 ± 0.47, p= 0.01), [18]
(3.41 ± 0.48 vs. 3.14 ± 0.40, p= 0.05) and [19] (3.33 ± 0.34
vs. 3.06 ± 0.29, p= 0.001).
Also, on measurement of septal wall thickness, it was signif-
icantly higher in our SLE patients compared to the control
(1.2 ± 0.29 vs. 0.9 ± 0.29, p= 0.02). Similar results were re-
ported in the following studies; [17] (0.92 ± 0.18 vs. 0.88 ±
0.15, p= 0.05), [18] (0.92 ± 0.09 vs. 0.10 ± 0.11, p = 0.05),
[19] (0.94 ± 0.12 vs. 0.84 ± 0.06, p= 0.001), and [20] (0.96
± 0.17 vs. 0.86 ± 0.15, p= 0.001).
No statistically signiﬁcant difference was found regarding
the other 2 D echo parameters as LVESD, LVEDD, PWT,
EF, FS, PW-E, PW-A, and E/A in the SLE patients compared
to the controls. These were found in other studies [18,19].On
the other hand, different results were reported by other
authors [17,20]. This could be attributed to racial differences
and to the small number of patients included in our study.
Regarding tissue Doppler ﬁndings, peak systolic velocity
was signiﬁcantly lower in SLE patients compared to the control
at the level of septum (0.10 ± 0.04 vs. 0.12 ± 0.03,) and at the
lateral mitral annulus (0.10 ± 0.01 vs. 0.12 ± 0.03,), our re-
sults were supported by the following studies; [18] (0.29 ± 0.9
vs. 0.39 ± 0.7 at septum) and (0.39 ± 1 vs. 0.51 ± 0.8 at lat-
eral mitral annulus), [19] (0.65 ± 2.35 vs. 0.86 ± 2.3 at septum)
and (0.75 ± 2.41 vs. 1.031 ± 2.95 at lateral mitral annulus)
and [20] (0.78 ± 1.54 vs 0.86 ± 0.92, at septum) and
(0.92 ± 2.2 vs. 1.1 ± 1.66 at lateral mitral annulus).
The peak early diastolic myocardial velocity (E wave) was
found to be signiﬁcantly lower in SLE patients compared to
the control (0.12 ± 0.04 vs. 0.15 ± 0.04, at the septum), and
(0.13 ± 0.01 vs. 0.15 ± 0.03 at the lateral mitral annulus).
Similar results were reported by others; [17–19].
The peak late diastolic myocardial velocity (A wave) was
signiﬁcantly lower in SLE patients compared to the control
(0.10 ± 0.04 vs. 0.12 ± 0.03, at the septum), (0.12 ± 0.04 vs.
0.15 ± 0.04 at the lateral mitral annulus). We had an agree-
ment with other studies [17,18].
Regarding the myocardial performance index, it was signif-
icantly prolonged in SLE patients compared to controls
(0.49 ± 0.11 vs. 0.34 ± 0.04 at the septum) and 0.53 ± 0.17
vs. 0.37 ± 0.04 at the lateral mitral annulus, and was similar
to that reported by other studies [14], in contrast to others [19].
Fourteen out of our 50 SLE patients were positive for ACL,
10 out of them had high MPI values. Antiphospholipid anti-
bodies could represent only one of the pathogenetic factors
of the cardiac lesions in SLE patients [21]. Similar to the study
[22], we found a signiﬁcant difference in the mean MPI value
between SLE patients with positive ACL and those with nega-
tive antibody (p= 0.01).
On comparing tissue Doppler ﬁndings between active and
inactive SLE groups, we found statistically signiﬁcant lower val-
ues of peak systolic myocardial velocity at the septum
(p= 0.019) and lateral mitral annulus (p= 0.013), peak early
diastolic myocardial velocity at septum (p= 0.013) and lateral
mitral annulus (p= 0.001), peak late diastolic myocardial
velocity at the septum (p= 0.013) and lateral mitral annulus
(p= 0.002) in the active group compared to the inactive group.
It has been reported [20], that the peak systolic velocity was sig-
niﬁcantly lower at the septum (6.68 ± 0.99 vs. 8.22 ± 1.51) and
at the lateral mitral annulus (7.82 ± 1.92 vs. 9.82 ± 2.05) in the
active patients compared to those with inactive disease. Also the
isovolumetric relaxation time (IRT) at the septum (p= 0.001)and the lateral mitral annulus (p= 0.003) was found to be pro-
longed in our active group compared to the inactive group, this
ﬁnding is supported by other studies [23,24].
Other studies [18,25] reported different ﬁndings as they did
not ﬁnd signiﬁcant differences between active and inactive
groups regarding the tissue Doppler parameters. However,
the active patients in the study [18] showed signiﬁcant reduction
in LV function when measured by strain rate and strain imag-
ing that are technological advancements that have been devel-
oped as a means to objectively quantify regional myocardial
function. So they concluded that strain rate was better than tis-
sue Doppler in detecting differences in LV function in SLE pa-
tients with active disease.
We can conclude that the SLE patients have an increased
prevalence of subclinical LV dysfunction. Although, the
parameters of 2D echocardiography were within normal range
in SLE patients, systolic and diastolic velocities of the LV mea-
sured by tissue Doppler were signiﬁcantly impaired in SLE pa-
tients compared to controls.
Regular monitoring of cardiac function by tissue Doppler is
recommended for SLE patients with the following risk factors:
old age, long disease duration, high disease activity.
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